176 related articles for article (PubMed ID: 17304523)
1. Synthesis of endotoxic principle of bacterial lipopolysaccharide and its recognition by the innate immune systems of hosts.
Kusumoto S; Fukase K
Chem Rec; 2006; 6(6):333-43. PubMed ID: 17304523
[TBL] [Abstract][Full Text] [Related]
2. Self and nonself recognition with bacterial and animal glycans, surveys by synthetic chemistry.
Fujimoto Y; Tanaka K; Shimoyama A; Fukase K
Methods Enzymol; 2010; 478():323-42. PubMed ID: 20816488
[TBL] [Abstract][Full Text] [Related]
3. Diversity of endotoxin and its impact on pathogenesis.
Trent MS; Stead CM; Tran AX; Hankins JV
J Endotoxin Res; 2006; 12(4):205-23. PubMed ID: 16953973
[TBL] [Abstract][Full Text] [Related]
4. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis.
Sawada N; Ogawa T; Asai Y; Makimura Y; Sugiyama A
Clin Exp Immunol; 2007 Jun; 148(3):529-36. PubMed ID: 17335558
[TBL] [Abstract][Full Text] [Related]
6. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide.
Kumada H; Haishima Y; Watanabe K; Hasegawa C; Tsuchiya T; Tanamoto K; Umemoto T
Oral Microbiol Immunol; 2008 Feb; 23(1):60-9. PubMed ID: 18173800
[TBL] [Abstract][Full Text] [Related]
7. Bacterial lipopolysaccharides and innate immunity.
Alexander C; Rietschel ET
J Endotoxin Res; 2001; 7(3):167-202. PubMed ID: 11581570
[TBL] [Abstract][Full Text] [Related]
8. TLR4 agonists as immunomodulatory agents.
Alderson MR; McGowan P; Baldridge JR; Probst P
J Endotoxin Res; 2006; 12(5):313-9. PubMed ID: 17059695
[TBL] [Abstract][Full Text] [Related]
9. Chemistry of lipid A: at the heart of innate immunity.
Molinaro A; Holst O; Di Lorenzo F; Callaghan M; Nurisso A; D'Errico G; Zamyatina A; Peri F; Berisio R; Jerala R; Jiménez-Barbero J; Silipo A; Martín-Santamaría S
Chemistry; 2015 Jan; 21(2):500-19. PubMed ID: 25353096
[TBL] [Abstract][Full Text] [Related]
10. The chemical structure of bacterial endotoxin in relation to bioactivity.
Rietschel ET; Kirikae T; Schade FU; Ulmer AJ; Holst O; Brade H; Schmidt G; Mamat U; Grimmecke HD; Kusumoto S
Immunobiology; 1993 Apr; 187(3-5):169-90. PubMed ID: 8330896
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization of carboxymethyl lipid A derivatives in relation to biological activity.
Seydel U; Schromm AB; Brade L; Gronow S; Andrä J; Müller M; Koch MH; Fukase K; Kataoka M; Hashimoto M; Kusumoto S; Brandenburg K
FEBS J; 2005 Jan; 272(2):327-40. PubMed ID: 15654872
[TBL] [Abstract][Full Text] [Related]
12. A case for an endotoxic conformation.
Seydel U; Brandenburg K; Rietschel ET
Prog Clin Biol Res; 1994; 388():17-30. PubMed ID: 7831357
[TBL] [Abstract][Full Text] [Related]
13. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
Saitoh S; Miyake K
Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
[TBL] [Abstract][Full Text] [Related]
14. A novel lipid A from Halomonas magadiensis inhibits enteric LPS-induced human monocyte activation.
Ialenti A; Di Meglio P; Grassia G; Maffia P; Di Rosa M; Lanzetta R; Molinaro A; Silipo A; Grant W; Ianaro A
Eur J Immunol; 2006 Feb; 36(2):354-60. PubMed ID: 16365914
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules.
Dunn-Siegrist I; Tissières P; Drifte G; Bauer J; Moutel S; Pugin J
J Biol Chem; 2012 May; 287(20):16121-31. PubMed ID: 22433865
[TBL] [Abstract][Full Text] [Related]
16. Innate immunomodulation by lipophilic termini of lipopolysaccharide; synthesis of lipid As from Porphyromonas gingivalis and other bacteria and their immunomodulative responses.
Fujimoto Y; Shimoyama A; Saeki A; Kitayama N; Kasamatsu C; Tsutsui H; Fukase K
Mol Biosyst; 2013 May; 9(5):987-96. PubMed ID: 23429860
[TBL] [Abstract][Full Text] [Related]
17. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
[TBL] [Abstract][Full Text] [Related]
18. From agonist to antagonist: structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxins.
DeMarco ML; Woods RJ
Mol Immunol; 2011 Oct; 49(1-2):124-33. PubMed ID: 21924775
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis, transport, and modification of lipid A.
Trent MS
Biochem Cell Biol; 2004 Feb; 82(1):71-86. PubMed ID: 15052329
[TBL] [Abstract][Full Text] [Related]
20. Recognition of lipid A variants by the TLR4-MD-2 receptor complex.
Maeshima N; Fernandez RC
Front Cell Infect Microbiol; 2013; 3():3. PubMed ID: 23408095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
